114 related articles for article (PubMed ID: 11026012)
1. [Medroxyprogesterone acetate for treatment of advanced breast cancers].
Mitsuyama S; Anan K
Nihon Rinsho; 2000 Apr; 58 Suppl():317-21. PubMed ID: 11026012
[No Abstract] [Full Text] [Related]
2. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
[TBL] [Abstract][Full Text] [Related]
3. [A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Kusama M; Kaise H; Nakayama S; Oota D; Shimizu H; Aoki T; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2243-7. PubMed ID: 11142170
[TBL] [Abstract][Full Text] [Related]
4. [Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma].
Higuchi K; Onda M; Furukawa K; Minobe K; Tanaka N; Arima Y; Hasegawa H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1799-802. PubMed ID: 9382536
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
6. [A case of advanced breast cancer that responded remarkably to chemotherapy].
Watanabe Y; Kaiga T; Ueda T; Fujii M
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2113-6. PubMed ID: 11103244
[TBL] [Abstract][Full Text] [Related]
7. [A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy].
Yamada T; Okazaki M; Okazaki A; Sato H; Watanabe Y; Toda K; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1923-5. PubMed ID: 1387777
[TBL] [Abstract][Full Text] [Related]
8. [Two cases of advanced breast cancer effectively treated with chemoendocrine therapy and radiotherapy].
Kimura M; Hagiwara S; Hirose K; Shimokawa Y; Iwai K; Uemura K
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2505-8. PubMed ID: 7944499
[TBL] [Abstract][Full Text] [Related]
9. [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1525-8. PubMed ID: 19755825
[TBL] [Abstract][Full Text] [Related]
10. [Sequencing of chemotherapy and radiotherapy following breast-preserving treatment of breast carcinoma].
Sauer R; Martus P
Strahlenther Onkol; 1996 Sep; 172(9):516-7. PubMed ID: 8928060
[No Abstract] [Full Text] [Related]
11. Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system.
Abe O; Asaishi K; Izuo M; Enomoto K; Koyama H; Tominaga T; Nomura Y; Ohshima A; Aoki N; Tsukada T
Surg Today; 1995; 25(8):701-10. PubMed ID: 8520164
[TBL] [Abstract][Full Text] [Related]
12. [Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers].
Okazaki M; Okazaki A; Masuoka H; Toda K; Yamada T; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():94-101. PubMed ID: 7747999
[TBL] [Abstract][Full Text] [Related]
13. [Recurrence of right breast cancer at the thoracic wall successfully treated with intra-arterial infusion of doxorubicin hydrochloride--a case report].
Hasegawa S; Yamamoto Y; Ishiwa N; Yoshikawa T; Morinaga S; Noguchi Y; Matsumoto A; Nishimura J; Okoshi T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2399-401. PubMed ID: 12484084
[TBL] [Abstract][Full Text] [Related]
14. [A case of giant advanced breast cancer responding remarkably to CEFT therapy].
Yano M; Kume K; Ono E; Wakasugi K; Matsuzaka T; Fujinaga H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1067-70. PubMed ID: 8512336
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up.
Hupperets P; Wils J; Volovics L; Schouten L; Fickers M; Bron H; Schouten H; Jager J; de Jong J; Beex L
Ann Oncol; 1995 Jan; 6(1):90-1. PubMed ID: 7710989
[No Abstract] [Full Text] [Related]
16. [Chemo-endocrine therapy including mitomycin C and medroxyprogesterone acetate in doxorubicin-refractory advanced breast cancer].
Nomura Y; Tashiro H; Shirouzu M; Takayama T
Gan To Kagaku Ryoho; 1996 Mar; 23(4):439-45. PubMed ID: 8678495
[TBL] [Abstract][Full Text] [Related]
17. [A case of far advanced breast cancer with distant metastases which had mostly disappeared after chemoendocrine therapy].
Nishimura H; Takasuna K; Kondo R; Hayashi K; Munakata Y; Kasuga Y
Gan To Kagaku Ryoho; 2000 May; 27(5):753-7. PubMed ID: 10832447
[TBL] [Abstract][Full Text] [Related]
18. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.
Akhtar MS; Kousar F; Masood M; Fatimi S; Kokab
J Coll Physicians Surg Pak; 2010 Nov; 20(11):748-52. PubMed ID: 21078249
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant chemo-endocrine therapy for early breast cancer patients--review of the literature].
Ikeda T; Masamura S; Hohjoh T; Kawaguchi M; Takayama S; Tokura H; Miyabe R; Kitajima M; Matsui A; Kikuchi K
Nihon Rinsho; 2000 Apr; 58 Suppl():203-8. PubMed ID: 11025996
[No Abstract] [Full Text] [Related]
[Next] [New Search]
